Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Human apo A-IV isolated from hypertriglyceridemic plasma; leaves open its role in lipid disorders for prospective validation.
A protein with properties similar to apoprotein A‐IV of Rat high‐density lipoproteins has been isolated from the lipoprotein fraction (δ < 1.006 g/ml) of individual non‐fasting hypertriglyceridaemic subjects. The M r of human apolipoprotein A‐IV determined by polyacrylamide‐gel electrophoresis in sodium dodecylsulfate and by column chromatography in 6 M guanidine hydrochloride is 46000. The amino acid composition is significantly different from any previously characterised human apolipoprotein but resembles that of rat apolipoprotein A‐IV. The N‐terminal amino acid of human and rat apolipoprotein A‐IV is glutamate or glutamine. The p I of the major human A‐IV band in 6 M urea is ∼ 5.15. Immunochemically apolipoprotein A‐IV is not identical with any of the well known human apolipoproteins. Human apolipoprotein A‐IV is present in all fractions of δ < 1.006 g/ml isolated by a single ultracentrifugal spin from non‐fasting subjects, but is lost from lipoproteins of δ < 1.006 g/ml upon recentrifugation. Immunoelectrophoretic studies show that most of human apolipoprotein A‐IV is present in the fraction of δ > 1.21 g/ml and is unassociated with the major lipoprotein fractions in serum. Charge‐shift electrophoresis however clearly demonstrates the hydrophobic character of human apolipoprotein A‐IV. There is evidence that apolipoprotein A‐IV is a constituent of chylomicrons that is removed from the particle surface when chylomicrons enter the plasma compartment.
No takes yet. Share an insight, caveat, or question.
Beisiegel et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: